MX359453B - Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad. - Google Patents
Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.Info
- Publication number
- MX359453B MX359453B MX2013010680A MX2013010680A MX359453B MX 359453 B MX359453 B MX 359453B MX 2013010680 A MX2013010680 A MX 2013010680A MX 2013010680 A MX2013010680 A MX 2013010680A MX 359453 B MX359453 B MX 359453B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- enhancing
- maintaining
- age related
- related maladies
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000002708 enhancing effect Effects 0.000 abstract 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000037411 cognitive enhancing Effects 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 210000003022 colostrum Anatomy 0.000 abstract 1
- 235000021277 colostrum Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161465404P | 2011-03-18 | 2011-03-18 | |
| PCT/US2012/028712 WO2012128982A2 (en) | 2011-03-18 | 2012-03-12 | Compositions and methods useful for ameliorating age related maladies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013010680A MX2013010680A (es) | 2013-10-03 |
| MX359453B true MX359453B (es) | 2018-09-28 |
Family
ID=46879965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013010680A MX359453B (es) | 2011-03-18 | 2012-03-12 | Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10010566B2 (enExample) |
| EP (1) | EP2685987B1 (enExample) |
| JP (1) | JP2014515011A (enExample) |
| CN (1) | CN104066342A (enExample) |
| AU (1) | AU2012231351B2 (enExample) |
| BR (1) | BR112013023770B1 (enExample) |
| CA (1) | CA2830476C (enExample) |
| ES (1) | ES2727043T3 (enExample) |
| MX (1) | MX359453B (enExample) |
| RU (1) | RU2600893C2 (enExample) |
| WO (1) | WO2012128982A2 (enExample) |
| ZA (1) | ZA201307770B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6648007B2 (ja) * | 2013-06-13 | 2020-02-14 | スマートフィッシュ・アーエス | アルツハイマー病の治療、遅延及び／又は予防において使用するための、レスベラトロール又はその誘導体を含む水産油配合物 |
| US8974832B1 (en) * | 2013-12-10 | 2015-03-10 | Lifewave, Inc. | Nutritional product composition for increasing human growth hormone and nitric oxide production |
| WO2016092479A1 (en) * | 2014-12-10 | 2016-06-16 | Subramaniam Vanangamudi Sulur | A pharmaceutical formulation comprising resveratrol, benfotiamine and pyridoxamine, a process of making it and a method of treatment using it |
| WO2016100826A1 (en) * | 2014-12-19 | 2016-06-23 | Avelis Llc | Mineral complex formulations for oral administration and methods for their use |
| US10660683B2 (en) * | 2016-05-27 | 2020-05-26 | In2Bones Usa, Llc | Method for sterile packaging of K-wire and cap |
| JP2019518744A (ja) * | 2016-05-27 | 2019-07-04 | ネステク ソシエテ アノニム | 運動障害を治療又は予防するための栄養組成物 |
| JPWO2018066394A1 (ja) * | 2016-10-04 | 2019-10-03 | 日本水産株式会社 | 筋肉を柔軟にするための組成物 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| JP7270546B2 (ja) * | 2017-04-11 | 2023-05-10 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 個体における認知的加齢を特定及び軽減するためのオメガ３脂肪酸及びビタミンｄレベル |
| MA49906A (fr) | 2017-08-14 | 2020-06-24 | Axcella Health Inc | Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie |
| EP3810123A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| EP3853356A4 (en) | 2018-09-20 | 2022-09-14 | Mystem Biotechnologies Inc. | STEM CELLS DERIVED FROM COLOSTRUM, NEURONAL DIFFERENTIATION, COMPOSITIONS AND SUPPLEMENTS FOR IMPROVING MAMMALIAN HEALTH |
| CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
| JP2021165235A (ja) * | 2020-04-06 | 2021-10-14 | 株式会社ファンケル | アトロジン−１発現抑制剤 |
| MX2023002625A (es) * | 2020-09-03 | 2023-03-17 | Nestle Sa | Composiciones y metodos para proporcionar beneficios para la salud en un animal. |
| US20250099515A1 (en) * | 2021-12-09 | 2025-03-27 | Societe Des Produits Nestle S.A. | Lactobacillus acidophilus to increase agmatine production by microbiota |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952033A (en) | 1996-12-24 | 1999-09-14 | Nestec S.A. | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same |
| EP0862863B9 (en) | 1997-01-09 | 2009-08-12 | Societe Des Produits Nestle S.A. | Cereal product containing probiotics |
| AUPP327198A0 (en) * | 1998-04-30 | 1998-05-21 | Northfield Laboratories Pty Ltd | A food composition and method of using same |
| US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
| AU783678B2 (en) | 1999-09-07 | 2005-11-24 | Societe Des Produits Nestle S.A. | Method for improving the skin and coat of pets |
| ID29913A (id) | 1999-09-22 | 2001-10-25 | Nestle Sa | Metode peningkatan aktivitas hewan peliharaan |
| JP4343477B2 (ja) | 2000-05-25 | 2009-10-14 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ペットフード用新規プロバイオチックス |
| WO2001091578A2 (en) | 2000-05-26 | 2001-12-06 | Societe Des Produits Nestle S.A. | Foodstuff for pets or other animals |
| AU2002243267A1 (en) * | 2000-10-27 | 2002-06-24 | Mannatech, Inc. | Dietary supplement compositions |
| US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
| GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| US20060014773A1 (en) * | 2001-04-19 | 2006-01-19 | Mccleary Edward L | Mental agility lozenge, edible strip, food or drink |
| US20040166206A1 (en) | 2003-02-25 | 2004-08-26 | Archibald William E. | Vacuum packaged food products and methods of making same |
| EP1344458A1 (en) | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
| WO2007022991A1 (en) * | 2005-08-26 | 2007-03-01 | Nestec S.A. | Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| CN101296693B (zh) * | 2005-10-26 | 2012-07-04 | 花王株式会社 | 持久力提高剂 |
| PL1800675T4 (pl) * | 2005-12-23 | 2012-02-29 | Nutricia Nv | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia |
| PL2004201T3 (pl) | 2006-03-29 | 2019-02-28 | Nestec S.A. | Suplementy diety zawierające probiotyki |
| JP2008189585A (ja) * | 2007-02-02 | 2008-08-21 | Qualicaps Co Ltd | 水溶性硬質カプセル剤 |
| JP2008214338A (ja) * | 2007-02-08 | 2008-09-18 | Shiseido Co Ltd | 高次脳機能低下改善剤および遅延記憶低下改善剤 |
| FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
| AU2008307494B2 (en) * | 2007-10-04 | 2013-09-05 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing cognitive function |
| CN101909632A (zh) * | 2008-01-04 | 2010-12-08 | 雀巢产品技术援助有限公司 | 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途 |
| US20100056484A1 (en) * | 2008-08-26 | 2010-03-04 | Scott Farese | Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress |
| CN101433241A (zh) * | 2008-12-05 | 2009-05-20 | 江苏星驰生物科技有限公司 | 配方牛初乳 |
| WO2010095926A1 (en) | 2009-02-20 | 2010-08-26 | N.V. Nutricia | Use of reveratrol for preserving cognitive functioning |
| JP5606004B2 (ja) * | 2009-03-31 | 2014-10-15 | 小林製薬株式会社 | 血中アルブミン量の増加促進または減少抑制用組成物 |
-
2012
- 2012-03-12 ES ES12760637T patent/ES2727043T3/es active Active
- 2012-03-12 CN CN201280022679.3A patent/CN104066342A/zh active Pending
- 2012-03-12 RU RU2013146517/15A patent/RU2600893C2/ru active
- 2012-03-12 US US14/004,947 patent/US10010566B2/en active Active
- 2012-03-12 BR BR112013023770-8A patent/BR112013023770B1/pt active IP Right Grant
- 2012-03-12 WO PCT/US2012/028712 patent/WO2012128982A2/en not_active Ceased
- 2012-03-12 EP EP12760637.4A patent/EP2685987B1/en active Active
- 2012-03-12 CA CA2830476A patent/CA2830476C/en active Active
- 2012-03-12 JP JP2013558083A patent/JP2014515011A/ja active Pending
- 2012-03-12 AU AU2012231351A patent/AU2012231351B2/en active Active
- 2012-03-12 MX MX2013010680A patent/MX359453B/es active IP Right Grant
-
2013
- 2013-10-17 ZA ZA2013/07770A patent/ZA201307770B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012128982A3 (en) | 2014-04-24 |
| CA2830476A1 (en) | 2012-09-27 |
| US10010566B2 (en) | 2018-07-03 |
| AU2012231351A1 (en) | 2013-09-26 |
| BR112013023770B1 (pt) | 2020-12-15 |
| WO2012128982A2 (en) | 2012-09-27 |
| ES2727043T3 (es) | 2019-10-11 |
| RU2600893C2 (ru) | 2016-10-27 |
| MX2013010680A (es) | 2013-10-03 |
| AU2012231351B2 (en) | 2016-03-10 |
| EP2685987A2 (en) | 2014-01-22 |
| CA2830476C (en) | 2019-09-24 |
| EP2685987A4 (en) | 2014-08-20 |
| ZA201307770B (en) | 2015-04-29 |
| US20140004205A1 (en) | 2014-01-02 |
| JP2014515011A (ja) | 2014-06-26 |
| EP2685987B1 (en) | 2019-04-24 |
| RU2013146517A (ru) | 2015-04-27 |
| BR112013023770A2 (pt) | 2016-12-06 |
| CN104066342A (zh) | 2014-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX359453B (es) | Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad. | |
| MX346576B (es) | Metodos y composiciones adecuados para promover piel sana. | |
| PH12019501339A1 (en) | Amino acid compositions and methods for the treatment of muscle diseases and disorders | |
| HK1205942A1 (en) | Compositions, methods, and kits for regulating energy metabolism | |
| MX2018009945A (es) | Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad. | |
| PH12013502465A1 (en) | Metabolic imprinting effects of specifically designed lipid component | |
| GB2503852A (en) | Compounds for the treatment of neuropsychiatric disorders | |
| BR112016000072A2 (pt) | composições orais | |
| BR112014009962A2 (pt) | anticorpos humanizados para inkt | |
| MX2015003048A (es) | Tratamiento del trastorno de estres post-traumatico con mycobacterium aislado. | |
| AU2016216741A1 (en) | Compositions and methods of use of an inappetance-controlling compound | |
| MX2015010296A (es) | Tratamiento de formas progresivas de esclerosis multiple con laquinimod. | |
| DK2714888T3 (da) | Rekombinant gær | |
| MY161933A (en) | Fortified Milk-Based Nutritional Compositions | |
| BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
| MX2019013864A (es) | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo. | |
| CA3079518C (en) | USE OF AMINO ACID SUPPLEMENTATION FOR IMPROVED MUSCLE PROTEIN SYNTHESIS | |
| NZ702645A (en) | A method of improving liver function | |
| WO2014031982A3 (en) | Methods and compositions for treating pain | |
| MX2019013207A (es) | Metodos y composiciones para tratar la endometriosis y sintomas asociados a la endometriosis. | |
| EA201492238A1 (ru) | Композиция мизопростола | |
| PH12015500530A1 (en) | Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof | |
| MX2016002714A (es) | Composicion y metodo para tropicalizar chocolate. | |
| MX368742B (es) | Metodo y composiciones para reducir los niveles sericos de triacilgliceridos en seres humanos con una lipasa fungica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |